Matthew Potter

Investor type:

Social media:

Available after registration.

Past investments

  • BARRX Medical
  • Lutonix
  • Karyopharm Therapeutics
  • Vital Therapies
  • Phenomix
  • Astute Medical
  • Calithera Biosciences
  • PTC Therapeutics
  • TriVascular
  • PolyRemedy
  • Sotera Wireless
  • Anulex Technologies
  • Acclarent
  • Barosense
  • Pivot Medical
  • ELENZA
  • PhotoThera
  • Sequent Medical
  • Evalve
  • LeddarTech
  • Relypsa
  • Aragon Surgical
  • Arbor Surgical Technologies
  • Syndicate
  • Cameron Health
  • PixelOptics
  • AEGEA Medical
  • Proteolix
  • EBR Systems
  • Primaeva Medical
  • Labcyte
  • Senseonics
  • NeurAxon
  • Breathe Technologies
  • Cardeas Pharma
  • Revance Therapeutics
  • VytronUS
  • NovaSys
  • ForSight Labs
  • Reliant Technologies
  • Tandem Diabetes Care
  • Vibrynt
  • Paracor Medical
  • NeuroVista
  • NOVASYS MEDICAL
  • Covalent
  • ForSight VISION5
  • Alder Biopharmaceuticals
  • SynergEyes
  • Ivantis
  • Proacta
  • OncoMed Pharmaceuticals